We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

60 hedge funds and large institutions have $33.9M invested in Cumberland Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less call options, than puts

Call options by funds: $1K | Put options by funds: $8K

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
60
Increased
–
Reduced
–
Closed
–
Calls
$1K
Puts
$8K
Net Calls
-$7K
Net Calls Change
-$7K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
Coldstream Capital Management
Washington
$178K +$174K +34,920 New
BFA
27
BlackRock Fund Advisors
California
$171K +$167K +33,552 New
PP
28
PDT Partners
New York
$155K +$151K +30,334 New
BAM
29
Berkshire Asset Management
Pennsylvania
$148K +$144K +29,000 New
Wellington Management Group
30
Wellington Management Group
Massachusetts
$141K +$137K +27,611 New
Bank of America
31
Bank of America
North Carolina
$136K +$132K +26,549 New
Two Sigma Investments
32
Two Sigma Investments
New York
$129K +$125K +25,200 New
Two Sigma Advisers
33
Two Sigma Advisers
New York
$121K +$117K +23,600 New
LMF
34
LMR Master Fund
Cayman Islands
$119K +$117K +23,416 New
State Street
35
State Street
Massachusetts
$111K +$109K +21,900 New
CI
36
Cowen Inc
New York
$101K +$98.5K +19,800 New
JP Morgan Chase
37
JP Morgan Chase
New York
$94K +$91.8K +18,455 New
Jane Street
38
Jane Street
New York
$85K +$83.1K +16,706 New
BCM
39
Bridgeway Capital Management
Texas
$84K +$82.1K +16,500 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$83K +$80.1K +16,094 New
U
41
UBS
Switzerland
$71K +$69K +13,872 New
DAM
42
Delta Asset Management
Tennessee
$56K +$54.7K +11,000 New
CS
43
Credit Suisse
Switzerland
$55K +$53.4K +10,733 New
Barclays
44
Barclays
United Kingdom
$55K +$53.5K +10,761 New
WIC
45
Woodmont Investment Counsel
Tennessee
$51K +$49.8K +10,000 New
NFA
46
Nationwide Fund Advisors
Ohio
$46K +$45.2K +9,087 New
WA
47
WealthTrust-Arizona
Arizona
$45K +$43.4K +8,720 New
AIG
48
American International Group
New York
$41.8K +$40.7K +8,182 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$36K +$34.9K +7,013 New
Citigroup
50
Citigroup
New York
$24K +$23.9K +4,797 New
1
2
3

CPIX Hedge Fund Activity: Q2 2013 in Review

60 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2013, worth a combined $33.9M.

Buyers outnumbered sellers: 60 funds opened new CPIX positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

  • 60 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $33.9M of Cumberland Pharmaceuticals stock for Q2 2013.
  • 60 funds opened new Cumberland Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +60 holders.

Based on aggregated 13F filings for Q2 2013.